Viral Vectors/Vaccines

A Clear Regulatory Pathway to Accelerate Your Vaccine & Viral Vector Development and Biomanufacturing

Achieve shorter lead times while maintaining vaccine safety using the only delivery platform that meets the scalability, consistency and cell type flexibility requirements for vaccine and viral vector development and manufacturing.

  • Reproducibly transfects a wide range of vaccine and virus-producing cell lines
  • Highly efficient (co)transfection of multiple, large plasmids
  • Eliminate the need to use baculovirus expression systems or generate stable cells
  • Safe, streamlined, cGMP-compliant manufacturing with increased yield
  • Scales from R&D to biomanufacturing using a cell-engineering technology with an FDA Master File


Viral Vector Manufacturing (Lentiviruses & AAVs)

VLP/VRP Production

Rapid Response Vaccines

Subunit Vaccines


Dendritic Cell Vaccines

Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter

Request Demo